- The University of California, Berkeley, and Bristol-Myers
Squibb Co. have jointly announced a $1 million gift from the
pharmaceutical company to the university to advance research
and graduate training in synthetic organic chemistry.
grant is a shared commitment between the Bristol-Myers Squibb
Pharmaceutical Research Institute and the Bristol-Myers Squibb
- the largest corporate contribution ever received by UC Berkeley's
Department of Chemistry - establishes Bristol-Myers Squibb
as the first sponsoring member of UC Berkeley's Center for
New Directions in Organic Chemistry. Formed last year, the
center will provide new opportunities to enhance graduate
training and research through collaborations among research
groups and between academe and industry, according to its
director, former chemistry chair Paul A. Bartlett. Bristol-Myers
Squibb's support reflects the company's recognition that graduate
training in organic synthesis is a high priority for the pharmaceutical
synthesis is critical to a broad range of industries in the
areas of health and technology, especially those engaged in
pharmaceutical discovery and biotechnology, and in the development
of new materials. UC Berkeley's new center has two foci, which
span the medicinal and materials applications of organic synthesis.
of the pharmaceutical and biotechnology industries has increased
the need for scientists skilled in synthesis. At the same
time, advances in areas like combinatorial chemistry and biological
catalysis require more sophisticated training at the graduate
is thus motivation in both industry and academe to find new
approaches to support organic synthesis, to augment traditional
funding mechanisms and continue to make the field attractive
to new students and faculty members," Bartlett said.
very excited by this opportunity to further strengthen our
relationship with UC Berkeley, and we look forward to collaboratively
addressing the issues associated with supporting and maintaining
high quality research in organic chemistry," said Dr. Peter
S. Ringrose, chief scientific officer and president of Bristol-Myers
Squibb's Pharmaceutical Research Institute, in announcing
the grant. "The grant reflects the company's continuing support
of exemplary academic research in synthetic organic chemistry,
as well as the ongoing training of new scientists."
grant will advance both graduate education and research, which
are inseparable in Berkeley's top-ranked chemistry department,"
said Clayton H. Heathcock, dean of the College of Chemistry
and one of the center's organizers. "We are enormously grateful
that Bristol-Myers Squibb has become a sponsoring member of
the center has seven other industrial members, who are participating
at a more modest level. The funds contributed by industry
will be used to modernize laboratories, as well as to support
the on-going work of the center. These activities include
short courses taught by UC Berkeley faculty for industrial
participants, summer internships provided by industry for
UC Berkeley students, and a graduate course in industrial
research featuring speakers from participating companies.
Squibb is a leading diversified worldwide health and personal
care company whose principal businesses are medicines, nutritional
products, medical devices and beauty care. Its foundation
supports activities that extend and enhance human life. Headquartered
in New York, the company has some 54,000 employees worldwide.
of Chemistry at UC Berkeley is both the top ranked chemistry
department in the nation and the largest, with 50 faculty
members, 350 graduate students and 250 postdoctoral fellows
carrying out advanced research across all fields of chemistry.